[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "CFO & Head of Corporate Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 54, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin  Andrulevich", "age": 58, "title": "Chief People Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.07, "open": 7.07, "dayLow": 6.78, "dayHigh": 7.14, "regularMarketPreviousClose": 7.07, "regularMarketOpen": 7.07, "regularMarketDayLow": 6.78, "regularMarketDayHigh": 7.14, "payoutRatio": 0.0, "beta": -0.063, "forwardPE": -5.0071945, "volume": 905968, "regularMarketVolume": 905968, "averageVolume": 1025158, "averageVolume10days": 1049290, "averageDailyVolume10Day": 1049290, "bid": 5.08, "ask": 8.7, "bidSize": 2, "askSize": 2, "marketCap": 609076544, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 5.571, "twoHundredDayAverage": 4.546375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 294764896, "profitMargins": 0.0, "floatShares": 57156091, "sharesOutstanding": 87511000, "sharesShort": 7119785, "sharesShortPriorMonth": 6015205, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.08140001, "heldPercentInsiders": 0.00298, "heldPercentInstitutions": 0.99085, "shortRatio": 6.3, "shortPercentOfFloat": 0.08140001, "impliedSharesOutstanding": 88894096, "bookValue": 3.49, "priceToBook": 1.9942694, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -91745000, "trailingEps": -1.03, "forwardEps": -1.39, "enterpriseToEbitda": -2.794, "52WeekChange": -0.037344396, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 6.96, "targetHighPrice": 34.0, "targetLowPrice": 14.0, "targetMeanPrice": 20.0, "targetMedianPrice": 18.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 315444992, "totalCashPerShare": 3.605, "ebitda": -105483000, "totalDebt": 1133000, "quickRatio": 24.427, "currentRatio": 24.698, "debtToEquity": 0.371, "returnOnAssets": -0.23966, "returnOnEquity": -0.35022998, "freeCashflow": -48282248, "operatingCashflow": -74359000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Terns Pharmaceuticals, Inc.", "regularMarketChangePercent": -1.55587, "regularMarketPrice": 6.96, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1756507795, "regularMarketTime": 1756497600, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -1.03, "epsForward": -1.39, "epsCurrentYear": -1.11978, "priceEpsCurrentYear": -6.215507, "fiftyDayAverageChange": 1.3889999, "fiftyDayAverageChangePercent": 0.24932685, "twoHundredDayAverageChange": 2.4136252, "twoHundredDayAverageChangePercent": 0.53089005, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "longName": "Terns Pharmaceuticals, Inc.", "postMarketChangePercent": -0.142243, "postMarketPrice": 6.9501, "postMarketChange": -0.00990009, "regularMarketChange": -0.11, "regularMarketDayRange": "6.78 - 7.14", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1025158, "fiftyTwoWeekLowChange": 5.0950003, "fiftyTwoWeekLowChangePercent": 2.7319036, "fiftyTwoWeekRange": "1.865 - 11.4", "fiftyTwoWeekHighChange": -4.4399996, "fiftyTwoWeekHighChangePercent": -0.38947365, "fiftyTwoWeekChangePercent": -3.7344396, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754424000, "isEarningsDateEstimate": true, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]